Supplier Quality Assurance Requires Hands-On, Risk-Based Strategy
This article was originally published in The Silver Sheet
Executive Summary
CONTROLLING THE QUALITY OF SUPPLIED PARTS AND MATERIALS can be a daunting task for device manufacturers, particularly when dealing with numerous contractors and components. Industry consultants recommend a risk-based approach to managing supplier relationships, with the most intensive evaluation and monitoring reserved for suppliers of critical parts. FDA investigators indicate that many firms are not devoting adequate attention and resources to purchasing control and incoming product acceptance activities; their observations are borne out by a steady stream of supplier-related citations in warning letters over the past couple years
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.